An Updated Review of Target-Specific Oral Anticoagulants Used in Stroke Prevention in Atrial Fibrillation, Venous Thromboembolic Disease, and Acute Coronary Syndromes

被引：23

作者：

Cove, Christina L. ^{[1
]}

Hylek, Elaine M. ^{[2
]}

机构：

[1] Boston Univ, Sch Med, Dept Cardiovasc Med, Boston, MA 02118 USA

[2] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA

来源：

JOURNAL OF THE AMERICAN HEART ASSOCIATION | 2013年 / 2卷 / 05期

基金：

美国国家卫生研究院;

关键词：

anticoagulants; apixaban; dabigatran; rivaroxaban; warfarin; FACTOR-XA INHIBITOR; TOTAL KNEE REPLACEMENT; TOTAL HIP; DABIGATRAN ETEXILATE; DOUBLE-BLIND; ANTITHROMBOTIC THERAPY; ANTIPLATELET THERAPY; RISK STRATIFICATION; PREDICTING STROKE; APIXABAN;

D O I：

10.1161/JAHA.113.000136

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页数：12

共 83 条

[31] A once-daily, oral, direct Factor Xa inhibitor, rivaroxaban (BAY 59-7939), for thromboprophylaxis after total hip replacement [J].

Eriksson, Bengt I. ;

Borris, Lars C. ;

Dahl, Ola E. ;

Haas, Sylvia ;

Huisman, Menno V. ;

Kakkar, Ajay K. ;

Muehlhofer, Eva ;

Dierig, Christoph ;

Misselwitz, Frank ;

Kalebo, Peter .

CIRCULATION, 2006, 114 (22) :2374-2381

[32] Oral dabigatran versus enoxaparin for thromboprophylaxis after primary total hip arthroplasty (RE-NOVATE II) A randomised, double-blind, non-inferiority trial [J].

Eriksson, Bengt I. ;

Dahl, Ola E. ;

Huo, Michael H. ;

Kurth, Andreas A. ;

Hantel, Stefan ;

Hermansson, Karin ;

Schnee, Janet M. ;

Friedman, Richard J. .

THROMBOSIS AND HAEMOSTASIS, 2011, 105 (04) :721-729

[33] Oral, direct Factor Xa inhibition with BAY 59-7939 for the prevention of venous thromboembolism after total hip replacement [J].

Eriksson, BI ;

Borris, L ;

Dahl, OE ;

Haas, S ;

Huisman, MV ;

Kakkar, AK ;

Misselwitz, F ;

Kälebo, P .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 (01) :121-128

[34] Prevention of VTE in Orthopedic Surgery Patients Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines [J].

Falck-Ytter, Yngve ;

Francis, Charles W. ;

Johanson, Norman A. ;

Curley, Catherine ;

Dahl, Ola E. ;

Schulman, Sam ;

Ortel, Thomas L. ;

Pauker, Stephen G. ;

Colwell, Clifford W., Jr. .

CHEST, 2012, 141 (02) :E278S-E325S

[35]

FDA, 2012, FDA ADV COMM BRIEF D

[36] Bleeding During Treatment With Aspirin Versus Apixaban in Patients With Atrial Fibrillation Unsuitable for Warfarin The Apixaban Versus Acetylsalicylic Acid to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin k Antagonist Treatment (AVERROES) Trial [J].

Flaker, Greg C. ;

Eikelboom, John W. ;

Shestakovska, Olga ;

Connolly, Stuart J. ;

Kaatz, Scott ;

Budaj, Andrzej ;

Husted, Steen ;

Yusuf, Salim ;

Lip, Gregory Y. H. ;

Hart, Robert G. .

STROKE, 2012, 43 (12) :3291-+

[37] Dabigatran versus enoxaparin for prevention of venous thromboembolism after hip or knee arthroplasty: A pooled analysis of three trials [J].

Friedman, R. J. ;

Dahl, O. E. ;

Rosencher, N. ;

Caprini, J. A. ;

Kurth, A. A. ;

Francis, C. W. ;

Clemens, A. ;

Hantel, S. ;

Schnee, J. M. ;

Eriksson, B. I. .

THROMBOSIS RESEARCH, 2010, 126 (03) :175-182

[38] 2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines 2006 WRITING COMMITTEE MEMBERS Developed in partnership with the European Society of Cardiology and in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society [J].

Fuster, Valentin ;

Ryden, Lars E. ;

Cannom, Davis S. ;

Crijns, Harry J. ;

Curtis, Anne B. ;

Ellenbogen, Kenneth A. ;

Halperin, Jonathan L. ;

Kay, G. Neal ;

Le Huezey, Jean-Yves ;

Lowe, James E. ;

Olsson, S. Bertil ;

Prystowsky, Eric N. ;

Tamargo, Juan Luis ;

Wann, L. Samuel ;

Estes, N. A. Mark, III ;

Ezekowitz, Michael D. ;

Jackman, Warren M. ;

January, Craig T. ;

Page, Richard L. ;

Slotwiner, David J. ;

Stevenson, William G. ;

Tracy, Cynthia M. ;

Jacobs, Alice K. ;

Anderson, Jeffrey L. ;

Albert, Nancy ;

Buller, Christopher E. ;

Creager, Mark A. ;

Ettinger, Steven M. ;

Guyton, Robert A. ;

Hochman, Judith S. ;

Kushner, Frederick G. ;

Ohman, Erik Magnus ;

Tarkington, Lynn G. ;

Yancy, Clyde W. .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (11) :E101-E198

[39] Adverse outcomes and predictors of underuse of antithrombotic therapy in medicare beneficiaries with chronic atrial fibrillation [J].

Gage, BF ;

Boechler, M ;

Doggette, AL ;

Fortune, G ;

Flaker, GC ;

Rich, MW ;

Radford, MJ .

STROKE, 2000, 31 (04) :822-827

[40] Validation of clinical classification schemes for predicting stroke - Results from the national registry of Atrial Fibrillation [J].

Gage, BF ;

Waterman, AD ;

Shannon, W ;

Boechler, M ;

Rich, MW ;

Radford, MJ .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (22) :2864-2870

← 1 2 3 4 5 6 7 8 9 →